Enhanced sensitivity to benzodiazepines in active cocaine-abusing subjects: a PET study - PubMed (original) (raw)
Enhanced sensitivity to benzodiazepines in active cocaine-abusing subjects: a PET study
N D Volkow et al. Am J Psychiatry. 1998 Feb.
Abstract
Objective: Because cocaine enhances dopamine brain activity and dopamine signals are transferred through gamma-aminobutyric acid pathways, the authors hypothesized GABA-ergic disruption in cocaine-abusing subjects. This study tests this hypothesis.
Method: GABA brain function was assessed indirectly by measuring the brain metabolic responses to lorazepam, a drug that facilitates GABA neurotransmission. Thirteen current cocaine-abusing subjects and 14 comparison subjects were scanned twice with positron emission tomography and [18F]fluorodeoxyglucose; the first scan was obtained after placebo administration and the second after lorazepam administration (30 micrograms/kg).
Results: Despite significantly higher plasma lorazepam concentrations in comparison subjects than in cocaine-abusing subjects, lorazepam-induced decrements in whole brain metabolism were significantly greater in cocaine-abusing (mean = 21%, SD = 13%) than in comparison (mean = 13%, SD = 7%) subjects. These differences were largest in striatum, thalamus, and parietal cortex. Lorazepam-induced sleepiness in cocaine-abusing subjects was intense and was significantly greater than in comparison subjects, and it was correlated with lorazepam-induced changes in thalamic metabolism. Whereas regional metabolic measures during placebo administration were significantly higher in cocaine-abusing subjects than in comparison subjects, the measures during lorazepam administration were equivalent for both groups.
Conclusions: The enhanced sensitivity to lorazepam in cocaine-abusing subjects suggests disruption of GABA pathways that may reflect, in part, cocaine withdrawal. The intense sleepiness induced by lorazepam in some of the abusers, despite their significantly lower plasma concentrations, should alert clinicians of the potential toxicity from accentuated responses to sedative hypnotics in active cocaine-abusing subjects.
Similar articles
- Decreased cerebral response to inhibitory neurotransmission in alcoholics.
Volkow ND, Wang GJ, Hitzemann R, Fowler JS, Wolf AP, Pappas N, Biegon A, Dewey SL. Volkow ND, et al. Am J Psychiatry. 1993 Mar;150(3):417-22. doi: 10.1176/ajp.150.3.417. Am J Psychiatry. 1993. PMID: 8382010 - Regional brain metabolism during alcohol intoxication.
Wang GJ, Volkow ND, Franceschi D, Fowler JS, Thanos PK, Scherbaum N, Pappas N, Wong CT, Hitzemann RJ, Felder CA. Wang GJ, et al. Alcohol Clin Exp Res. 2000 Jun;24(6):822-9. Alcohol Clin Exp Res. 2000. PMID: 10888070 Clinical Trial. - Depression of thalamic metabolism by lorazepam is associated with sleepiness.
Volkow ND, Wang GJ, Hitzemann R, Fowler JS, Pappas N, Lowrimore P, Burr G, Pascani K, Overall J, Wolf AP. Volkow ND, et al. Neuropsychopharmacology. 1995 Apr;12(2):123-32. doi: 10.1016/0893-133X(94)00068-B. Neuropsychopharmacology. 1995. PMID: 7779240 - Neurobiology of cocaine addiction: implications for new pharmacotherapy.
Kalivas PW. Kalivas PW. Am J Addict. 2007 Mar-Apr;16(2):71-8. doi: 10.1080/10550490601184142. Am J Addict. 2007. PMID: 17453607 Review. - Neurobiology of cocaine-induced organic brain impairment: contributions from functional neuroimaging.
Strickland TL, Miller BL, Kowell A, Stein R. Strickland TL, et al. Neuropsychol Rev. 1998 Mar;8(1):1-9. doi: 10.1023/a:1025613322003. Neuropsychol Rev. 1998. PMID: 9585919 Review.
Cited by
- Residual deficits in functional brain activity after chronic cocaine self-administration in rhesus monkeys.
Porrino LJ, Smith HR, Beveridge TJR, Miller MD, Nader SH, Nader MA. Porrino LJ, et al. Neuropsychopharmacology. 2023 Jan;48(2):290-298. doi: 10.1038/s41386-021-01136-w. Epub 2021 Aug 12. Neuropsychopharmacology. 2023. PMID: 34385608 Free PMC article. - GABAergic polygenic risk for cocaine use disorder is negatively correlated with precuneus activity during cognitive control in African American individuals.
Yang BZ, Balodis IM, Kober H, Worhunsky PD, Lacadie CM, Gelernter J, Potenza MN. Yang BZ, et al. Addict Behav. 2021 Mar;114:106695. doi: 10.1016/j.addbeh.2020.106695. Epub 2020 Oct 10. Addict Behav. 2021. PMID: 33153773 Free PMC article. - Dopaminergic impact of cART and anti-depressants on HIV neuropathogenesis in older adults.
Matt SM, Gaskill PJ. Matt SM, et al. Brain Res. 2019 Nov 15;1723:146398. doi: 10.1016/j.brainres.2019.146398. Epub 2019 Aug 21. Brain Res. 2019. PMID: 31442412 Free PMC article. Review. - The thalamus in drug addiction: from rodents to humans.
Huang AS, Mitchell JA, Haber SN, Alia-Klein N, Goldstein RZ. Huang AS, et al. Philos Trans R Soc Lond B Biol Sci. 2018 Mar 19;373(1742):20170028. doi: 10.1098/rstb.2017.0028. Philos Trans R Soc Lond B Biol Sci. 2018. PMID: 29352027 Free PMC article. Review. - Clinical efficacy of sertraline alone and augmented with gabapentin in recently abstinent cocaine-dependent patients with depressive symptoms.
Mancino MJ, McGaugh J, Chopra MP, Guise JB, Cargile C, Williams DK, Thostenson J, Kosten TR, Sanders N, Oliveto A. Mancino MJ, et al. J Clin Psychopharmacol. 2014 Apr;34(2):234-9. doi: 10.1097/JCP.0000000000000062. J Clin Psychopharmacol. 2014. PMID: 24525654 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical